Rheumatology Advance Access originally published online on February 21, 2006
Rheumatology 2006 45(5):645-646; doi:10.1093/rheumatology/kel033
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LETTER TO THE EDITOR |
ß2-Glycoprotein I IgA antibodies and ischaemic stroke
Rheumatology Department, Saint Lucas Hospital, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil and 1 INOVA Diagnostics, San Diego, CA, USA
Correspondence to: H. L. Staub, Rheumatology Department, Saint Lucas Hospital, Pontifical Catholic University of Rio Grande do Sul, Av. Ipiranga 6690/220, Porto Alegre Rio Grande do Sul 90610-000. Brazil. E-mail: henriquestaub{at}terra.com.br
SIR, Regarding the article by Kahles et al., recently published in this journal [1], we would like to point out that our previous paper, published in 2003 [2] and not referred to by Kahles et al., had already shown an association of IgA antibodies to ß2-glycoprotein I (ß2gpI) with ischaemic stroke. Like Kahles et al., we conducted a casecontrol study with multivariate analysis. This also allowed us to evaluate risk association after adjustment for known risk factors for stroke. Our data showed that the presence of IgA anti-ß2gpI antibodies was independently associated with the risk of acute cerebral ischaemia (adjusted odds ratio 4.6; 90% confidence interval 1.514.3; P = 0.025). ß2gpI is present in atheroma plaques [3]. The occurrence of IgA anti-ß2gpI antibodies in patients with ischaemic stroke brings about a possible link of autoimmunity with thrombophilia and/or atherosclerosis.
G.L.N. is an employee of INOVA Diagnostics Inc. He does not hold any stock or equity interest in the company.
References
- Kahles T, Humpich M, Steinmetz H, Sitzer M, Lindhoff-Last E. Phosphatidylserine IgG and beta2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke. Rheumatology 2005;44:11615.
[Abstract/Free Full Text] - Staub HL, Norman GL, Crowther T et al. Antibodies to the atherosclerotic plaque components beta2-glycoprotein I and heat-shock proteins as risk factors for acute cerebral ischaemia. Arq Neuropsiquiatr 2003;61:75763.[Medline]
- George J, Harats D, Gilburd B et al. Immunolocalization of beta2-gpI(apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. Circulation 1999;99:222730.
[Abstract/Free Full Text]
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||